GO
Loading...

Abbott Laboratories

More

  • Recall hurts Abbott, but still tops expectations Wednesday, 16 Apr 2014 | 9:56 AM ET

    ABBOTT PARK, Ill.— Abbott Laboratories' first-quarter net income tumbled 31 percent on unfavorable currency exchanges and a supplier recall that lowered sales of its baby formula. Baby formula sales fell 7 percent to $909 million after a recall in August that the company said cut its revenue by $75 million.

  • *Novartis reviewing fate of animal health, vaccines and OTC units. BASEL, Switzerland, March 20- Novartis Chief Executive Joe Jimenez is taking a hard look at the drugmaker's smaller businesses as he reshapes the company for what he expects to be a "brutal" new era in healthcare spending.

  • *Market leader Abbott, others still investing in India. *GlaxoSmithKline spends $1 bln to raise India unit stake. The two top foreign players, Abbott Laboratories and GlaxoSmithKline Plc, are actually stepping up investment, and others such as AstraZeneca Plc are considering doing so.

  • SAN FRANCISCO, March 10- A U.S. appeals court ruling that significantly boosted gay rights will stand, as a pharmaceutical company involved in the case said on Monday that it would not appeal.

  • NEW YORK, March 3- Russia's military move on the Crimean peninsula has raised tensions between Moscow and the West to levels not seen since the Cold War ended, but U.S. investors are not yet ready to sell, duck or cover.

  • *Danone to overhaul China milk powder range in 2014. SHANGHAI, Feb 20- In Danone SA's China, diamonds are free, milk powder is forever. With investors restless over its inability to grow in China, this month Danone paid $665 million to lift its small stake in the country's number two milk maker, China Mengniu Dairy Co Ltd..

  • Diamonds and deals as Danone struggles for China bounce Wednesday, 19 Feb 2014 | 4:00 PM ET

    SHANGHAI, Feb 20- In Danone SA's China, diamonds are free, milk powder is forever. With investors restless over its inability to grow in China, this month Danone paid $665 million to lift its small stake in the country's number two milk maker, China Mengniu Dairy Co Ltd..

  • LONDON/ FRANKFURT, Feb 12- France's Danone is weighing a sale of its tube feeding products business which could fetch over 3 billion euros as it expands its dairy business in higher-growth emerging markets, three people familiar with the deal said.

  • MUMBAI, Feb 12- India's Piramal Enterprises Ltd said it will join with Canada Pension Plan Investment Board to set up a $500 million fund to finance residential property projects in India.

  • Midday movers: Apple, Intel, Dollar Tree & More Wednesday, 22 Jan 2014 | 12:30 PM ET

    Wednesday's midday movers:

  • *Glaxo had sought $571 million, was awarded $3.5 mln. SAN FRANCISCO, Jan 21- A gay man was improperly excluded from jury service because of his sexual orientation, a federal appeals court has ruled, illustrating the widening influence of a key U.S. Supreme Court decision on gay rights.

  • *Glaxo had sought $571 million, was awarded $3.5 mln. SAN FRANCISCO, Jan 21- A gay man was improperly excluded from jury service because of his sexual orientation, a federal appeals court has ruled, illustrating the widening influence of a key U.S. Supreme Court decision on gay rights.

  • SAN FRANCISCO, Jan 21- GlaxoSmithKline Plc deserves a new trial against Abbott Laboratories because Abbott impermissibly excluded a potential juror based on his sexual orientation, a federal appeals court ruled on Tuesday.

  • My top 10 stocks for 2014: Farr Tuesday, 31 Dec 2013 | 8:42 AM ET

    What 10 stocks does trader Michael Farr think are going to deliver in 2014? Click ahead to find out.

  • Private equity firm Carlyle Group is nearing an agreement to acquire a Johnson & Johnson unit, people familiar with the matter said.

  • SHANGHAI/ WELLINGTON, Dec 17- Milk powder buyers in China are starting to cut their reliance on New Zealand's Fonterra, opening the way for U.S. and European firms to break the dairy giant's grip on an infant milk formula market set to double to $25 billion by 2017..

  • Lightning Round: BP, Abbott Labs & More Thursday, 12 Dec 2013 | 6:42 PM ET

    It’s time for the Lightning Round. Cramer makes the call on viewer favorites.

  • WELLINGTON/ PARIS, Dec 2- New Zealand dairy exporter Fonterra may face legal action from France's Danone over the recall of infant formula containing a potentially contaminated Fonterra ingredient, the company said on Monday.

  • WELLINGTON, Dec 2- New Zealand dairy exporter Fonterra said on Monday it may face legal action from France's Danone over the recall of infant formula containing a potentially contaminated Fonterra ingredient.

  • Nov 18- AbbVie Inc said a late-stage trial of its experimental oral hepatitis C treatment showed about 96 percent of patients had no detectable levels of the virus after 12 weeks. AbbVie shares rose 3 percent. Shares of Enanta Pharmaceuticals Inc, which collaborates with AbbVie on one of the drugs included in the treatment, rose 4 percent.

Most Popular Video

Wednesday, 16 Apr 2014 | 12:25 PM ET

CNBC's Steve Liesman provides insight into the highlights of Fed Chair Janet Yellen's comments at The Economic Club of New York.

Wednesday, 16 Apr 2014 | 12:15 PM ET

Josh Spencer, T. Rowe Price portfolio manager, encourages investors to get some guts and buy into growth stocks like Tesla and Amazon. He shares his opinions on some of the old tech names.

Wednesday, 16 Apr 2014 | 10:01 AM ET

Discussing how to buy in volatile market conditions and the investment banking market, David Katz, Matrix Asset Advisors CIO, and Charles Bobrinskoy, Ariel Investments vice chairman & portfolio manager.